Myom ve infertilite - PowerPoint PPT Presentation

1 / 36
About This Presentation
Title:

Myom ve infertilite

Description:

Clinically relevant fibroids (uterine enlargement greater than or equal to nine weeks size, fibroid greater than or equal to 4 cm, or submucosal fibroid) ... – PowerPoint PPT presentation

Number of Views:287
Avg rating:3.0/5.0
Slides: 37
Provided by: aaa8151
Category:

less

Transcript and Presenter's Notes

Title: Myom ve infertilite


1
Myom ve infertilite
Dr. Engin OralIstanbul Üniversitesi Cerrahpasa
Tip FakültesiKadin Hastaliklari ve Dogum ABD
2
Myom ve fertilite Sorular
  • Myom infertiliteye yol açar mi
  • Implantasyon
  • abortus
  • Myom varligi IVF sonuçlarini etkiler mi
  • Myomektomi fertilite üzerine etkili mi
  • Hangi yöntem (L/S vs L/P) fertilite icin daha
    iyi

3
Myom-Risk Faktörleri
  • Kanitlanmis
  • Seks, irk
  • Yas
  • Parite
  • Erken menars
  • Sigara içmek
  • Muhtemel
  • OK
  • Diyet
  • Aile anamnezi
  • Alkol
  • P iceren enjectabl
  • Obesite
  • Hipertansiyon
  • Uterus enfeksiyonu
  • PKOS

Stewart EA, 2009, UpToDate,
4
Myom-infertilityincidence
  • It has been estimated that uterine myomas are
    associated with infertility in 5 to 10 of
    cases. However, when all other causes of
    infertility are excluded, myomas may be
    responsible for only 2 to 3 of infertility cases

5
Fibroid-Infertility
Somigliana E, 2007
6
Mechanisms by which myomas cause reduced
fertility have been suggested
  • 1. Displacement of the cervix that may reduce
    exposure to sperm
  • 2. Enlargement or deformity of the uterine cavity
    that may interfere with sperm migration and
    transport
  • 3. Obstruction of the proximal fallopian tubes
  • 4. Altered tubo-ovarian anatomy, interfering with
    ovum capture
  • 5. Increased or disordered uterine contractility
    that may hinder sperm or embryo transport or
    nidation
  • 6. Distortion or disruption of the endometrium
    and implantation due to atrophy or venous ectasia
    over or opposite a submucous myoma
  • 7. Impaired endometrial blood flow
  • 8. Endometrial inflammation or secretion of
    vasoactive substances

Fertilization
implantation
7
Summary of Potential Mechanisms by Which Uterine
Fibroids May Have an Effect on Embryo Implantation
Andrew W. Horne, , 2007
8
Submucosal uterine leiomyomas have a global
effecton molecular determinants of endometrial
receptivity
Beth W. Rackow, and Hugh S. Taylor, In press F
S
9
Myom da yönetim
  • Yas
  • Semptomlar
  • Obstetrik geçmis
  • Fertilite plani
  • Büyüklügü
  • Yeri

10
(No Transcript)
11
Yerlesim
  • Submüköz
  • Tip 0 Saf submüköz
  • Tip I Intramural kisim 50den az
  • Tip II Intramural kisim 50den fazla
  • Intramural Kaviteyi bozmayan ve 50den azi
    seroza disina çikan
  • Subseröz 50den fazlasi seroza disina tasan

12
Location of Fibroids Affects Success of ART Cycles
Fibroids of Patients Pregnancy Rates
None 318 30.1
Subserosal 33 34.1
Intramural 46 16.4
Submucosal 9 10.0
Eldar-Geva et al., 1998
13
Effects of the position of fibroids on fertility
N 181
Casini ML, 2006
14
Klatsky PC, 2008
15
Fibroids and reproductive outcomes a
systematicliterature review from conception to
delivery
OR 1.82 (1.43-2.30) OR 1.34 (1.04, 1.65)
Klatsky PC, 2008
16
Donnez J and Jadoul P, 2002
17
PR /After myomectomy
L/S 49 L/T 48 H/S 45
Donnez J and Jadoul P, 2002
18
Asymptomatic uterine fibroids
  • For the younger woman who wishes to conceive now,
    whose fibroids are less than 1214 weeks in size
    and slow growing, she should be encouraged to try
    to conceive, and observed carefully for
    complications that may be attributable to the
    fibroids.
  • The younger woman who wishes to conceive now,
    whose fibroids are larger than 14 weeks in size
    but slow growing, should also be encouraged to
    try to conceive and observed carefully. However,
    if the fibroids are growing rapidly and/or she
    fails to conceive within 6 months, she should be
    counselled for myomectomy
  • The younger woman wishing to conceive in the
    future, whose fibroids are less than 1214 weeks
    in size and slow growing, should be kept under
    surveillance with regular (at least annual)
    ultrasound scans to assess fibroid behaviour.
  • If the fibroids are already more than 14 weeks in
    size and slow growing, she can be kept under
    surveillance although she should be discouraged
    from leaving it too long to conceive. She should
    also be informed of treatment options including
    myomectomy and the less-invasiveprocedures
    referred to above.

Hema Divakar, 2008
19
Asymptomatic uterine fibroids
  • In summary, most women with asymptomatic fibroids
    can be encouraged to try to conceive without any
    intervention being undertaken for the fibroids,
    and the vast majority will indeed conceive.
  • There are special circumstances where a case can
    be made for intervention, especially where the
    fibroids are submucous, intramural and distorting
    the cavity, and/or rapidly growing. Evidence does
    not support routine myomectomy before assisted
    reproductive technology in women with
    asymptomatic fibroids that do not distort the
    endometrial cavity significantly or cause
    abnormal uterine bleeding, but resection of
    submucous fibroids improves fertility rates.

Hema Divakar, 2008
20
Myomas and Assisted Reproduction Techniques
  • Five meta-analyses have aimed to assess the
    impact of fibroids on IVF cycles.
  • Pritts EA. Fibroids and infertility a systematic
    review of the evidence. Obstet Gynecol Surv
    20015648391
  • Donnez J, Jadoul P. What are the implications of
    myomas on fertility? A need for a debate? Hum
    Reprod 200217142430
  • Benecke C, Kruger TF, Siebert TI, Van der Merwe
    JP, Steyn DW. Effect of fibroids on fertility in
    patients undergoing assisted reproduction. A
    structured literature review. Gynecol Obstet
    Invest 20055922530.
  • Somigliana E, Vercellini P, Daguati R, Pasin R,
    De Giorgi O, Somigliana E, Vercellini P, Daguati
    R, Pasin R, De Giorgi O, Crosignani PG. Fibroids
    and female reproduction a critical analysis
    ofthe evidence. Hum Reprod Update 20071346576.

21
Of 347 studies initially evaluated, 23 were
included in the data analysis . One randomized
controlled treatment trial was identified , nine
prospective studies were included (one matched,
eight cohort) , and the remainder were
retrospective.
Elizabeth A. Pritts, William H. Parker, and
David L. Olive, 2009
22
Fibroids and infertility an updated systematic
review of the evidence
Elizabeth A. Pritts, William H. Parker, and
David L. Olive, 2009
23
Fibroids and infertility an updated systematic
review of the evidence
Elizabeth A. Pritts, William H. Parker, and
David L. Olive, 2009
24
Fibroids and infertility an updated systematic
review of the evidence
Elizabeth A. Pritts, William H. Parker, and
David L. Olive, 2009
25
Fibroids and infertility an updated systematic
review of the evidence
Elizabeth A. Pritts, William H. Parker, and
David L. Olive, 2009
26
Fibroids and infertility an updated systematic
review of the evidence
Elizabeth A. Pritts, William H. Parker, and
David L. Olive, 2009
27
Fibroids and infertility an updated systematic
review of the evidence
Elizabeth A. Pritts, William H. Parker, and
David L. Olive, 2009
28
Myomas and reproductive functionThe Practice
Committee of the American Society for
Reproductive Medicine-2008
  • The effects of myomas on reproductive function
    outcome are not well defined. Overall, evidence
    suggests that myomas are the primary cause of
    infertility in a relatively small proportion of
    women.
  • Myomas that distort the uterine cavity and
    larger intramural myomas may have adverse effects
    on fertility.
  • Medical treatment for myomas does not improve
    infertility.
  • In infertile women and those with recurrent
    pregnancy loss, myomectomy should be considered
    only after a thorough evaluation has been
    completed.
  • Myomectomy is a relatively safe surgical
    procedure associated with few serious
    complications. However, postoperative adhesions
    are common after abdominal myomectomy and pose a
    significant potential threat to subsequent
    fertility.
  • UAE, myolysis, and MRI-guided ultrasonic
    treatment should not be recommended for women
    with myomas seeking to maintain or improve their
    fertility because their safety and effectiveness
    in such women has not been established.

29
Submucous myomas and their implications in
thepregnancy rates of patients with otherwise
unexplained primary infertility undergoing
hysteroscopic myomectomy a randomized
matchedcontrol study
Tarek Shokeir, 2009
30
Submucous myomas and their implications in
thepregnancy rates of patients with otherwise
unexplained primary infertility undergoing
hysteroscopic myomectomy a randomized
matchedcontrol study
Tarek Shokeir, 2009
31
Proposed flow chart for the management of women
seeking conception in the presence of uterine
myomas
Edgardo Somigliana, 2008
32
Cerrahi
Bekle veya ART
Yas Yerlesim Sayi Çap Diger infertilite nedenleri
lt 38 Intramural gt1 3 cm Yok
38 Subseröz 1 lt3cm Var
33
RECOMMENDATIONSUpToDate
  • We suggest women with asymptomatic leiomyomas not
    postpone pregnancy, if possible, since
    leiomyomas, combined with advanced maternal age,
    may impair fertility and adversely impact
    pregnancy (Grade 2C).
  • In women planning pregnancy, we suggest not
    performing prophylactic myomectomy to prevent
    pregnancy complications (Grade 2C).

Togas Tulandi, MD, 2009
34
  • The relationship between leiomyomas and
    infertility is controversial. Couples should
    complete a full infertility evaluation before
    addressing the role of leiomyomas in their
    infertility
  • In women with asymptomatic leiomyomas who are
    infertile or have a history of recurrent
    pregnancy loss
  • For those with a myoma that is submucosal or has
    an intracavitary component, we suggest myomectomy
    (Grade 2C).
  • For women with a myoma that is subserosal, we
    suggest against myomectomy (Grade 2C).
  • For women with intramural fibroids that do not
    distort the uterine cavity, other sources of
    infertility should be addressed prior to a
    myomectomy. The decision to perform a myomectomy
    should be made based on patient preference and
    clinical factors (eg, obstructing of a fallopian
    tube or the cervical canal or failure of other
    infertility treatments).

35
  • We suggest myomectomy for women planning to
    undergo in vitro fertilization who have a
    submucosal fibroid or an intramural fibroid that
    deforms the uterine cavity (Grade 2C).
  • We suggest surgical myomectomy over medical
    therapy or embolization for women planning future
    pregnancies (Grade 2C).

36
Medical therapy
  • Several other nonsurgical treatments exist for
    uterine fibroids (gonadotropin-releasing hormone
    agonists, danazol, raloxifene, mifepristone,
    aromatase inhibitors, and the levonorgestrel-conta
    ining intrauterin system), but none has been
    shown to be of value in the patient desiring
    future fertility

37
Laparoscopic versus open myomectomyA
meta-analysis of randomizedcontrolled trials
  • Six studies and 576 patients were studied
  • laparoscopic myomectomy was associated with
  • less hemoglobin drop,
  • reduced operative blood loss,
  • more patients fully recuperated at day 15,
  • diminished postoperative pain, and fewer overall
    complications
  • but longer operation time.
  • However, major complications, pregnancy and
    recurrence were comparable in the two groups.

Chu Jin, 2009
Write a Comment
User Comments (0)
About PowerShow.com